246762 Acceptability of the Human papilloma virus (HPV) vaccine among adolescent males

Monday, October 31, 2011: 11:00 AM

Baudelio Gutierrez Jr. , Department of Epidemiology and Biostatistics, Drexel School of Public Health, Philadelphia, PA
Anthony Leung , Department of Epidemiology and Biostatistics, Drexel School of Public Health, Philadelphia, PA
Kevin Jones, MEd, MPH , HIV Prevention Research Division, University of Pennsylvania, Philadelphia, PA
Peter Smith , University of Pennsylvania, Philadelphia, PA
Amy Leader, DrPH, MPH , Department of Medical Oncology, Division of Population Science, Thomas Jefferson University, Philadelphia, PA
In 2009, the FDA extended approval of the HPV vaccine in eligible males between the ages of 9 to 26. New prophylactic HPV vaccines can lead to a significant reduction in HPV infections, thus decreasing the burden of HPV-related diseases in the US. This study investigates the decision factors that influence adolescent males to be receptive to vaccination.

Adolescent males completed a survey and participated in one of 7 focus group discussions to assess their attitudes and acceptability toward HPV and the HPV vaccine. Quantitative analysis consisted primarily of frequency distributions of survey items, while qualitative analysis consisted of iterative rounds of open-coding for thematic trends and concepts in the focus group transcripts.

46 adolescents (83% African-American; 15% Hispanic; mean age 15 years; 78% sexually active) participated. From the survey, 17% had heard of HPV and 22% had heard of the vaccine. 24% knew that HPV was the most common STI and only 22% knew that it was the primary cause of anogenital warts. Concerns over the vaccine's side-effects and efficacy were prevalent among adolescents. Getting vaccinated to minimize their female sexual partners' risk was a significant factor. Few believed that getting the HPV vaccine would encourage more males to get vaccinated. 27% of the teens were undecided about vaccination, 20% were in favor of vaccination, and 53% were against vaccination.

Knowledge of HPV and the vaccine was low among adolescent males. Increased awareness HPV and the vaccine would benefit adolescent males who are considering and/or engaging in sexual activity.

Learning Areas:
Assessment of individual and community needs for health education
Planning of health education strategies, interventions, and programs
Public health or related research
Social and behavioral sciences

Learning Objectives:
1. Compare rates of HPV infection among adolescent males to rates among female adolescents in other sub-populations 2. Evaluate the direct and indirect protective effects the vaccination has for adolescent males 3. Assess HPV vaccine acceptance and refusal to understand how to relate adolescent behavior and sexual health education

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Principal Investigator of the study
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.